1.Zhu, N et al. (2020) A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine 382, 727–733.
2.Tan, WJ et al. (2020) A novel coronavirus genome identified in a cluster of pneumonia cases – Wuhan, China 2019–2020. China CDC Weekly 2, 61–62.
5.World Health Organization. Coronavirus disease (COVID-19) outbreak. 2020. Available at https://www.who.int.
6.National Health Commission & National Administration of Traditional Chinese Medicine (2020) Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7). Chinese Medical Journal 133, 1087–1095.
7.Ye, GM et al. (2020) Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. The Journal of Infection 80, e14–e17.
8.Ravioli, S, Ochsner, H and Lindner, G (2020) Reactivation of COVID-19 pneumonia: a report of two cases. The Journal of Infection S0163–4453, 30279–6.
9.Loconsole, D et al. (2020) Recurrence of COVID-19 after recovery: a case report from Italy. Infection, 1–3.
10.Hoang, VT, Dao, TL and Gautret, P (2020) Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19. Journal of Medical Virology. doi: 10.1002/jmv.26056.
11.Cao, H et al. (2020) The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge. Journal of Medical Virology. doi: 10.1002/jmv.26017.
12.Yuan, J et al. (2020) PCR assays turned positive in 25 discharged COVID-19 patients. Clinical Infectious Disease, ciaa398.
13.Chen, M et al. (2020) Clinical characteristics of rehospitalized patients with COVID-19 in China. Journal of Medical Virology. doi: 10.1002/jmv.26002.
14.Jiang, ML et al. (2020) Recurrent PCR positivity after hospital discharge of people with coronavirus disease 2019 (COVID-19). The Journal of Infection 81, 147–178.
15.Li, YJ et al. (2020) Positive result of Sars-Cov-2 in faeces and sputum from discharged patient with COVID-19 in Yiwu, China. Journal of Medical Virology. doi: 10.1002/jmv.25905.
16.Xiao, AT, Tong, YX and Zhang, S (2020) False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence. Journal of Medical Virology. doi: 10.1002/jmv.25855.
17.Lan, L et al. (2020) Positive RT-PCR test results in patients recovered from COVID-19. JAMA 323, 1502–1503.
18.Zhou, L, Liu, K and Liu, HG (2020) Cause analysis and treatment strategies of ‘recurrence’ with novel coronavirus pneumonia (COVID-19) patients after discharge from hospital. Zhonghua Jie He He Hu Xi Za Zhi 43, 281–284.
19.Guan, WJ et al. (2020) Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine 382, 1708–1720.
20.Wang, DW et al. (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061–1069.
21.Chen, NS et al. (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England) 395, 507–513.
22.Fan, ZY et al. (2020) Clinical features of COVID-19-related liver functional abnormality. Clinical Gastroenterology and Hepatology 18, 1561–1566.
23.Cai, QX et al. (2020) COVID-19: abnormal liver function tests. Journal of Hepatology S0168–8278, 30218-X.
24.Kukla, M et al. (2020) COVID-19 and liver dysfunction: a systematic review and meta-analysis of retrospective studies. Journal of Medical Virology. doi: 10.1002/jmv.26055.
25.Chen, T et al. (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368, m1091.
26.Zhang, C, Shi, L and Wang, FS (2020) Liver injury in COVID-19: management and challenges. The Lancet Gastroenterology & Hepatology 5, 428–430.
27.Huang, CL et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 395, 497–506.
29.Guan, GW et al. (2020) Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia. Zhonghua Gan Zang Bing Za Zhi 28, 100–106.
30.Wang, YJ et al. (2020) SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. Journal of Hepatology S0168–8278, 30294–4.
31.Li, J and Fan, JG (2020) Characteristics and mechanism of liver injury in 2019 coronavirus disease. Journal of Clinical and Translational Hepatology 8, 13–17.
32.Cao, B et al. (2020) A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. The New England Journal of Medicine 382, 1787–1799.
33.Prompetchara, E, Ketloy, C and Palaga, T (2020) Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pacific Journal of Allergy and Immunology 38, 1–9.
34.Feng, G et al. (2020) COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies. Journal of Clinical and Translational Hepatology 8, 18–24.
35.Hundt, MA et al. (2020) Abnormal liver tests in COVID-19: a retrospective observational cohort study of 1827 patients in a major U.S. Hospital network. Hepatology. [published online ahead of print, 2020 Jul 29].